Wyonch, Blomqvist – Drug Price Regulation Update
From: Rosalie Wyonch and Åke Blomqvist To: Canadian drug regulators Date: August 22, 2019 Subject: Drug Price Regulation Update Yesterday, the federal government released revised rules for regulation of drug prices by the Patented Medicine Prices Review Board (PMPRB), whose mandate is to protect public and private payers from “excessive” prices for patented medicines. The changes are expected to result […] Bhatia, Falk – It’s Long Past Time For Virtual Healthcare In Canada
From: R. Sacha Bhatia and Will Falk To: Canada’s Healthcare Policymakers Date: August 16, 2019 Re: It’s Long Past Time for Virtual Healthcare in Canada Virtual care is a natural next step in technological innovation for healthcare, which has the potential to improve both quality of life for patients, and access to care in remote areas, all while increasing […] Wyonch, Robson – A Second Opinion On Ottawa’s Pharmacare Report
From: Rosalie Wyonch and William B.P. Robson To: Canadians concerned about healthcare Date: July 15, 2019 Re: A Second Opinion on Ottawa’s Pharmacare Report The final report of the federal Advisory Council on the Implementation of National Pharmacare recommends a universal pharmacare program with Ottawa covering all incremental costs. We offer a second opinion. There are better, cheaper […] There are better, cheaper ways to get Canadians the medications they need – National Post Op-Ed
The final report of the federal Advisory Council on the Implementation of National Pharmacare, which was chaired by former Ontario health minister Eric Hoskins, recommends a universal pharmacare program with Ottawa covering all incremental costs. We offer a second opinion. There are better, cheaper ways to achieve the same goal.
The council’s proposal would begin by covering 136 essential medicines as of 2022. As many observers have repeatedly warned, a one-size national program would not mesh well with existing provincial drug programs, nor with the provincially managed and funded doctor and hospital services that run alongside them. Because provincial tax-funded drug programs have varying levels of coverage and costs, the…
Rosalie Wyonch – Canada Selling Drugs to the US: Be Careful of the Price Trap
From: Rosalie Wyonch To: Canadian drug regulators Date: July 8, 2019 Subject: Canada Selling Drugs to the US: Be Careful of the Price Trap There is one issue that unites polarized politicians in the United States: drug prices. Both Bernie Sanders and Donald Trump have said they support importing lower-priced drugs from Canada as an easy solution to high […] Rosalie Wyonch – Legal Cannabis and the Black Market
From: Rosalie Wyonch To: Canadians concerned about cannabis Date: July 3, 2019 Subject: Legal Cannabis and the Black Market Cannabis has been legal in Canada for almost nine months, but there is still a long way to go before the legal market reaches its full potential. The government recently released the regulations for cannabis concentrates and edible products […] Robson, Wyonch – Hoskins Pharmacare Report: Enthusiasm for Drugs Can Impair Memory
To: Canadians concerned about healthcare From: William B.P. Robson and Rosalie Wyonch Date: June 17, 2019 Re: Hoskins Pharmacare Report: Enthusiasm for Drugs Can Impair Memory The Advisory Council on the Implementation of National Pharmacare released its final report last week. It recommends implementing a universal pharmacare program for all Canadians and that the federal government cover all […] S1 E8 – Universal Pharmacare
Are there better options for getting Canadians the medications they need? Our health policy expert, Rosalie Wyonch, sits down with Michael to discuss the report released by Dr. Eric Hoskins calling for Ottawa to create a national pharmacare plan. Read the full report Rosalie Wyonch – Quebec’s Pharmacare Didn’t Break The Bank
From: Rosalie Wyonch To: Canadian concerned about pharmacare Date: June 11, 2019 Subject: Quebec’s Pharmacare Didn’t Break the Bank One option for achieving universal prescription drug insurance coverage would see each province include drugs alongside doctors and hospital bills in the existing medicare system. In my new C.D. Howe Institute paper, I evaluate various options for implementing universal pharmacare […] Filling the Gaps: A Prescription for Universal Pharmacare
Universal pharmacare coverage for Canadians is within reach, based on cost estimates in a new C.D. Howe Institute study. In “Filling the Gaps: A Prescription for Universal Pharmacare,” authors Rosalie Wyonch and William Robson find there are ways to close the gaps in prescription drug coverage and protect households from excessive costs when in acute need through the […] Rosalie Wyonch – Drug Prices: Talking Beyond the Talking Points
From: Rosalie Wyonch To: Canada’s Pharmaceutical Price-Setters Date: June 3, 2019 Subject: Drug Prices: Talking Beyond the Talking Points Drug prices and whether they are too high, too low, or just right is currently a hotly debated topic in Canada. On one hand, governments and consumers assert that drug costs are growing unsustainably. On the other hand, patenting pharmaceutical […] Rosalie Wyonch – The Fallacy of Federal Advantage in Delivering Pharmacare
To: Canadians concerned about healthcare From: Rosalie Wyonch Date: May 14, 2019 Re: The Fallacy of Federal Advantage in Delivering Pharmacare One popular argument in favour of a national approach to pharmacare is that a strong federal role could lower total expenditures on drugs in Canada. The savings could occur through two channels. First, the […]